RYLCX
Price
$77.41
Change
-$0.24 (-0.31%)
Updated
Aug 25 closing price
Net Assets
14.17M
USLUX
Price
$21.66
Change
-$0.29 (-1.32%)
Updated
Aug 25 closing price
Net Assets
50.82M
Interact to see
Advertisement

RYLCX vs USLUX

Header iconRYLCX vs USLUX Comparison
Open Charts RYLCX vs USLUXBanner chart's image
Rydex Leisure C
Price$77.41
Change-$0.24 (-0.31%)
VolumeN/A
Net Assets14.17M
US Global Investors Global Luxury Goods
Price$21.66
Change-$0.29 (-1.32%)
VolumeN/A
Net Assets50.82M
RYLCX vs USLUX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYLCX vs. USLUX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLCX is a Buy and USLUX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
USLUX has more cash in the bank: 50.8M vs. RYLCX (14.2M). USLUX (0.56) and RYLCX (0.53) have matching dividends . RYLCX was incepted earlier than USLUX: RYLCX (24 years) vs USLUX (31 years). RYLCX (2.44) is less costly to investors than USLUX (1.95). RYLCX is a more actively managed with annual turnover of: 263.00 vs. USLUX (195.00). RYLCX has a lower initial minimum investment than USLUX: RYLCX (2500) vs USLUX (5000). RYLCX annual gain was more profitable for investors over the last year : 23.81 vs. USLUX (3.69). USLUX return over 5 years is better than : 31.49 vs. RYLCX (27.59).
RYLCXUSLUXRYLCX / USLUX
Total Expense Ratio2.391.75137%
Annual Report Gross Expense Ratio2.441.95125%
Fund Existence24 years31 years-
Gain YTD12.2438.463145%
Front LoadN/AN/A-
Min. Initial Investment2500500050%
Min. Initial Investment IRA1000N/A-
Net Assets14.2M50.8M28%
Annual Yield % from dividends0.530.5695%
Returns for 1 year23.813.69646%
Returns for 3 years50.0634.53145%
Returns for 5 years27.5931.4988%
Returns for 10 years58.7614.32410%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZMTF0.45N/A
+0.98%
Azimut Exploration Inc.
SOOBF42.10N/A
N/A
Sapporo Holdings, Ltd.
JCRRF5.00N/A
N/A
JCR PHARMACEUTICALS CO LTD.
PNYG0.25N/A
N/A
PONY GROUP INC.
ALPMY11.26-0.23
-2.00%
Astellas Pharma, Inc.